Dasatinib

Red

Brand Name(s):Sprycel

Indication:Acute lymphoblastic leukaemia

Chronic myeloid leukaemia

Chronic Phase Philadelphia-Chromosome positive

Rationale:1,2,3

Considered:Dec-06

Review Date:Aug-23

Comments:
NICE TA 426
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaDasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia
NICE TA425
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaDasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia
Dec-16
…………………………
Drug Safety Update
Patients should be tested for hepatitis B virus before starting treatment with BCR-ABL tyrosine kinase inhibitors.
May2016